These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 25452586)

  • 1. Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody response.
    Her Z; Teng TS; Tan JJ; Teo TH; Kam YW; Lum FM; Lee WW; Gabriel C; Melchiotti R; Andiappan AK; Lulla V; Lulla A; Win MK; Chow A; Biswas SK; Leo YS; Lecuit M; Merits A; Rénia L; Ng LF
    EMBO Mol Med; 2015 Jan; 7(1):24-41. PubMed ID: 25452586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-mediated enhancement aggravates chikungunya virus infection and disease severity.
    Lum FM; Couderc T; Chia BS; Ong RY; Her Z; Chow A; Leo YS; Kam YW; Rénia L; Lecuit M; Ng LFP
    Sci Rep; 2018 Jan; 8(1):1860. PubMed ID: 29382880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A potent neutralizing IgM mAb targeting the N218 epitope on E2 protein protects against Chikungunya virus pathogenesis.
    Lam S; Nyo M; Phuektes P; Yew CW; Tan YJ; Chu JJ
    MAbs; 2015; 7(6):1178-94. PubMed ID: 26305993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct Roles of Interferon Alpha and Beta in Controlling Chikungunya Virus Replication and Modulating Neutrophil-Mediated Inflammation.
    Cook LE; Locke MC; Young AR; Monte K; Hedberg ML; Shimak RM; Sheehan KCF; Veis DJ; Diamond MS; Lenschow DJ
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31619554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TLR3 mediated innate immune response in mice brain following infection with Chikungunya virus.
    Priya R; Patro IK; Parida MM
    Virus Res; 2014 Aug; 189():194-205. PubMed ID: 24905288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Chikungunya Virus Monoclonal Antibody That Inhibits Viral Fusion and Release.
    Tumkosit U; Siripanyaphinyo U; Takeda N; Tsuji M; Maeda Y; Ruchusatsawat K; Shioda T; Mizushima H; Chetanachan P; Wongjaroen P; Matsuura Y; Tatsumi M; Tanaka A
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chikungunya Virus Fidelity Variants Exhibit Differential Attenuation and Population Diversity in Cell Culture and Adult Mice.
    Riemersma KK; Steiner C; Singapuri A; Coffey LL
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caribbean and La Réunion Chikungunya Virus Isolates Differ in Their Capacity To Induce Proinflammatory Th1 and NK Cell Responses and Acute Joint Pathology.
    Teo TH; Her Z; Tan JJ; Lum FM; Lee WW; Chan YH; Ong RY; Kam YW; Leparc-Goffart I; Gallian P; Rénia L; de Lamballerie X; Ng LF
    J Virol; 2015 Aug; 89(15):7955-69. PubMed ID: 25995257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A chikungunya fever vaccine utilizing an insect-specific virus platform.
    Erasmus JH; Auguste AJ; Kaelber JT; Luo H; Rossi SL; Fenton K; Leal G; Kim DY; Chiu W; Wang T; Frolov I; Nasar F; Weaver SC
    Nat Med; 2017 Feb; 23(2):192-199. PubMed ID: 27991917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune-Mediated Protection and Pathogenesis of Chikungunya Virus.
    Fox JM; Diamond MS
    J Immunol; 2016 Dec; 197(11):4210-4218. PubMed ID: 27864552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High rate of subclinical chikungunya virus infection and association of neutralizing antibody with protection in a prospective cohort in the Philippines.
    Yoon IK; Alera MT; Lago CB; Tac-An IA; Villa D; Fernandez S; Thaisomboonsuk B; Klungthong C; Levy JW; Velasco JM; Roque VG; Salje H; Macareo LR; Hermann LL; Nisalak A; Srikiatkhachorn A
    PLoS Negl Trop Dis; 2015 May; 9(5):e0003764. PubMed ID: 25951202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil Extracellular Traps Effectively Control Acute Chikungunya Virus Infection.
    Hiroki CH; Toller-Kawahisa JE; Fumagalli MJ; Colon DF; Figueiredo LTM; Fonseca BALD; Franca RFO; Cunha FQ
    Front Immunol; 2019; 10():3108. PubMed ID: 32082301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic Chikungunya Virus Evades B Cell Responses to Establish Persistence.
    Hawman DW; Fox JM; Ashbrook AW; May NA; Schroeder KMS; Torres RM; Crowe JE; Dermody TS; Diamond MS; Morrison TE
    Cell Rep; 2016 Aug; 16(5):1326-1338. PubMed ID: 27452455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chikungunya-specific IgG and neutralizing antibody responses in natural infection of Chikungunya virus in children from India.
    Verma A; Nayak K; Chandele A; Singla M; Ratageri VH; Lodha R; Kabra SK; Murali-Krishna K; Ray P
    Arch Virol; 2021 Jul; 166(7):1913-1920. PubMed ID: 33907861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-Neutralizing Anti-Chikungunya and Anti-Dengue 2 IgG Antibodies from Patients and BALB/c Mice against Dengue and Chikungunya Viruses.
    Posadas-Mondragón A; Santiago-Cruz JA; Pérez-Juárez A; Herrera-González NE; Sosa-Delgado SM; Wong-Arámbula CE; Rodríguez-Maldonado AP; Vázquez-Pichardo M; Duran-Ayala D; Aguilar-Faisal JL
    Viruses; 2024 Jul; 16(7):. PubMed ID: 39066260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A small antigenic determinant of the Chikungunya virus E2 protein is sufficient to induce neutralizing antibodies which are partially protective in mice.
    Weber C; Büchner SM; Schnierle BS
    PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003684. PubMed ID: 25905779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A lipid-encapsulated mRNA encoding a potently neutralizing human monoclonal antibody protects against chikungunya infection.
    Kose N; Fox JM; Sapparapu G; Bombardi R; Tennekoon RN; de Silva AD; Elbashir SM; Theisen MA; Humphris-Narayanan E; Ciaramella G; Himansu S; Diamond MS; Crowe JE
    Sci Immunol; 2019 May; 4(35):. PubMed ID: 31101672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Neutralization Assay Using an eGFP Chikungunya Virus.
    Deng CL; Liu SQ; Zhou DG; Xu LL; Li XD; Zhang PT; Li PH; Ye HQ; Wei HP; Yuan ZM; Qin CF; Zhang B
    Viruses; 2016 Jun; 8(7):. PubMed ID: 27367716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term persistence of Chikungunya virus neutralizing antibodies in human populations of North Eastern Thailand.
    Nitatpattana N; Kanjanopas K; Yoksan S; Satimai W; Vongba N; Langdatsuwan S; Nakgoi K; Ratchakum S; Wauquier N; Souris M; Auewarakul P; Gonzalez JP
    Virol J; 2014 Oct; 11():183. PubMed ID: 25330992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple immune factors are involved in controlling acute and chronic chikungunya virus infection.
    Poo YS; Rudd PA; Gardner J; Wilson JA; Larcher T; Colle MA; Le TT; Nakaya HI; Warrilow D; Allcock R; Bielefeldt-Ohmann H; Schroder WA; Khromykh AA; Lopez JA; Suhrbier A
    PLoS Negl Trop Dis; 2014 Dec; 8(12):e3354. PubMed ID: 25474568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.